Prammer K V, Boyer J, Ugen K, Shattil S J, Kieber-Emmons T
Wistar Institute of Anatomy and Biology, University of Pennsylvania School of Medicine, Philadelphia.
Receptor. 1994 Summer;4(2):93-108.
Antibodies can mimic the biological function of physiological ligands, yet few examples indicate the structural similarity between antibodies and the ligands that they mimic. Originally, the competition of antibodies for ligand binding sites was conjectured to be through similar three-dimensional conformations, which represent the "internal image" of the given ligand. Here we show that residues in a complementary determining region (CDR) can adopt the same bioactive structures observed in ligands. Structure-function studies of three anti-GPIIb-IIIa murine monoclonal antibodies, PAC-1, LJ-CP3, and OP-G2, indicate that the RYD sequence in their H-CDR3 domain occupies the same conformational space as RGD in conformationally constrained, bioactive, GPIIb-IIIa cell-surface adhesion ligands. The relative location of the guanidinium and carboxylate groups in the RXD regions is identified as an important recognition feature, and the conformational space occupied by this region in the antibodies is only slightly larger than that in the most bioactive peptides. Additionally, we show that antibodies can unveil other potential bioactive sequences, which may impart specificity. Thus antibodies are an exquisite probe for identifying motifs of short adhesion stretches, thereby revealing amino acid sequences and restricted geometries that might be used as lead compounds in drug design.
抗体能够模拟生理配体的生物学功能,但很少有例子表明抗体与其模拟的配体之间存在结构相似性。最初,人们推测抗体与配体结合位点的竞争是通过相似的三维构象进行的,这些构象代表了给定配体的“内影像”。在此我们表明,互补决定区(CDR)中的残基可以采用在配体中观察到的相同生物活性结构。对三种抗血小板糖蛋白IIb-IIIa(GPIIb-IIIa)小鼠单克隆抗体PAC-1、LJ-CP3和OP-G2的结构-功能研究表明,它们重链互补决定区3(H-CDR3)结构域中的RYD序列与构象受限的、具有生物活性的GPIIb-IIIa细胞表面黏附配体中的RGD占据相同的构象空间。RXD区域中胍基和羧基的相对位置被确定为一个重要的识别特征,并且该区域在抗体中占据的构象空间仅略大于在最具生物活性的肽中的构象空间。此外,我们表明抗体可以揭示其他潜在的生物活性序列,这些序列可能赋予特异性。因此,抗体是用于识别短黏附片段基序的精妙探针,从而揭示可能用作药物设计先导化合物的氨基酸序列和受限几何结构。